Instructions To avoid having to fill out the web form each time, you may login to the site first. Here are the instructions

Tell Congress to Support the Protecting Our Pharmaceutical Supply Chain from China Act of 2020
Take Action (Step 1 of 2)

Senator Tom Cotton (R-Arkansas) and Congressman Mike Gallagher (R-Wisconsin) recently introduced the Protecting our Pharmaceutical Supply Chain from China Act, in both the House and the Senate.

This bill would end U.S. dependence on China for pharmaceutical manufacturing. The bill's key restrictions would go into effect in 2022 and have no impact on the current coronavirus pandemic. No FDA resources will be diverted to begin implementation.

Specifically, the bill will:

  • Track active pharmaceutical ingredients through an FDA registry.
  • Prohibit pharmaceutical purchases from China or products with active pharmaceutical ingredients created in China*.
  • Create transparency in the supply chain by instituting a country of origin label of all imported drugs.
  • Provide economic incentives for manufacturing drugs and medical equipment in the United States.

Click here to read more about the Protecting Our Pharmaceutical Supply Chain from China Act of 2020.

To send an email to your local US Representative and both of your US Senators, in support of this crucial legislation, please fill out the required fields below and click continue.